News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fujisawa Pharmaceutical Co., Ltd. And Carlsson Research AB Conclude Licensing Agreement For Antipsychotic Agent ACR-16



10/19/2005 5:12:39 PM

Tokyo (JCNN) - Fujisawa Pharmaceutical (TSE: 4511) has announced that it has singed a licensing agreement with Carlsson Research, a Swedish pharmaceutical R&D company that has developed ACR-16, a new type of antipsychotic agent.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES